Next Article in Journal
Using Multiple Approaches in Docking Pose Evaluation – Application to the GABAA Receptor
Previous Article in Journal
Pluronic® F-68 Enhances the Nanoparticle-Cell Interaction
 
 
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Abstract

Validation of Fluorimetric Assay of Histone Deacetylase for Inhibitors from Plant Origin

Department of Pharmacognosy, University Vienna, Althanstraße 14, 1090, Vienna, Austria
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2009, 77(6), 180; https://doi.org/10.3797/scipharm.oephg.21.SL-13
Submission received: 16 April 2009 / Accepted: 16 April 2009 / Published: 16 April 2009

Abstract

Histone deacetylase inhibitors (HDACi) have received high interest as anti-cancer agents recently. HDACi may influence tumor growth by an inhibition of angiogenesis as well as by increasing tumor cell immunogenicity [1]. In many clinical trials the effect of several HDACi on different tumors are studied at the moment [2].

Share and Cite

MDPI and ACS Style

KRASTEVA, S.M.; KRENN, L. Validation of Fluorimetric Assay of Histone Deacetylase for Inhibitors from Plant Origin. Sci. Pharm. 2009, 77, 180. https://doi.org/10.3797/scipharm.oephg.21.SL-13

AMA Style

KRASTEVA SM, KRENN L. Validation of Fluorimetric Assay of Histone Deacetylase for Inhibitors from Plant Origin. Scientia Pharmaceutica. 2009; 77(Short Lectures (SL)):180. https://doi.org/10.3797/scipharm.oephg.21.SL-13

Chicago/Turabian Style

KRASTEVA, S. M., and L. KRENN. 2009. "Validation of Fluorimetric Assay of Histone Deacetylase for Inhibitors from Plant Origin" Scientia Pharmaceutica 77, Short Lectures (SL): 180. https://doi.org/10.3797/scipharm.oephg.21.SL-13

Article Metrics

Back to TopTop